Skin disease study to improve treatment choices
Part of Blood & lymphatic, Cancer, Genetic & congenital, Heart & circulation, Immune system & allergy, Infections, Skin clinical trials.
This study looks at different skin diseases to find markers that can help guide treatment. It tests new treatments for several conditions like eczema, psoriasis, and lupus, with the goal of personalizing care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older and not pregnant.
- You have one of these skin conditions: atopic dermatitis, cutaneous lupus, chronic hives, hidradenitis suppurativa, mycosis fungoides, or psoriasis.
- You are willing to start a new treatment for your skin condition as part of the study.
- You can avoid washing the study skin area for 12 hours before each visit.
- You agree to not get pregnant during the study (if female).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with chronic skin conditions over time, using questionnaires and photos taken at home. It tests whether digital monitoring can improve care and help doctors track your condition between visits.
This study looks at certain immune cells (called MAIT cells) in the skin of people with hidradenitis suppurativa, a painful skin condition. It will compare samples from people before they start a new biologic treatment, and may help doctors understand how these treatments work.
This study looks at the health records of people with skin diseases to learn more about their care and outcomes. It may help improve future treatments.
This study aims to better understand inducible urticaria (hives triggered by cold, pressure, or friction) and chronic spontaneous urticaria. Researchers will use skin tests to measure how different triggers affect your skin in detail.
This trial looks at how well standard treatments work for chronic skin conditions like atopic dermatitis, prurigo nodularis, psoriasis, chronic hand eczema, and hidradenitis suppurativa. It's observational, so it just tracks your progress during your normal care.
This study looks for clues in your skin and blood that could predict how well you'll respond to treatments for conditions like eczema, psoriasis, or lupus. It aims to help doctors choose the best therapy for you.
Hear when a new Psoriasis (PsO) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.